Gilead Sciences (GILD) Non-Current Deffered Revenue (2009 - 2013)

Gilead Sciences (GILD) has 5 years of Non-Current Deffered Revenue data on file, last reported at $22.0 million in Q4 2013.

• For the quarter ending Q4 2013, Non-Current Deffered Revenue rose 7.05% year-over-year to $22.0 million; the trailing twelve-month figure through Dec 2013 stood at $22.0 million (up 7.05% YoY), and the FY2013 full-year result was $22.0 million, up 7.05% from the prior year.
• Non-Current Deffered Revenue for Q4 2013 stood at $22.0 million, down from $25.4 million in the prior quarter.
• Across five years, Non-Current Deffered Revenue topped out at $53.4 million in Q2 2009 and bottomed at $20.5 million in Q4 2012.
• The 5-year median for Non-Current Deffered Revenue is $31.1 million (2011), against an average of $32.2 million.
• The widest annual swing landed in 2012, when Non-Current Deffered Revenue tumbled 39.96%; it then grew 21.89% in 2013.
• A 5-year view of Non-Current Deffered Revenue shows it stood at $43.0 million in 2009, then decreased by 23.66% to $32.8 million in 2010, then decreased by 2.97% to $31.9 million in 2011, then sank by 35.58% to $20.5 million in 2012, then advanced by 7.05% to $22.0 million in 2013.
• The last three Non-Current Deffered Revenue figures came in at $22.0 million (Q4 2013), $25.4 million (Q3 2013), and $28.8 million (Q2 2013), per Business Quant data.

Peer Comparison